Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.

Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C.

Br J Haematol. 2019 Jun 10. doi: 10.1111/bjh.16014. [Epub ahead of print]

PMID:
31180135
2.

Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.

Brace KM, Lee WW, Cole PD, Sussman ES.

J Clin Exp Neuropsychol. 2019 Jun 3:1-18. doi: 10.1080/13803395.2019.1623865. [Epub ahead of print]

PMID:
31156064
3.

Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort.

Ladas EJ, Orjuela M, Stevenson K, Cole PD, Lin M, Athale UH, Clavell LA, Leclerc JM, Laverdiere C, Michon B, Schorin MA, Welch JG, Asselin BL, Sallan SE, Silverman LB, Kelly KM.

Clin Nutr. 2019 Jan 3. pii: S0261-5614(18)32589-5. doi: 10.1016/j.clnu.2018.12.021. [Epub ahead of print]

PMID:
30639117
4.

Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.

Jhawar SR, Rivera-Núñez Z, Drachtman R, Cole PD, Hoppe BS, Parikh RR.

JAMA Oncol. 2019 Jan 3. doi: 10.1001/jamaoncol.2018.5911. [Epub ahead of print]

PMID:
30605220
5.

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.

Cole PD, McCarten KM, Pei Q, Spira M, Metzger ML, Drachtman RA, Horton TM, Bush R, Blaney SM, Weigel BJ, Kelly KM.

Lancet Oncol. 2018 Sep;19(9):1229-1238. doi: 10.1016/S1470-2045(18)30426-1. Epub 2018 Aug 16.

PMID:
30122620
6.

Methotrexate causes persistent deficits in memory and executive function in a juvenile animal model.

Wen J, Maxwell RR, Wolf AJ, Spira M, Gulinello ME, Cole PD.

Neuropharmacology. 2018 Sep 1;139:76-84. doi: 10.1016/j.neuropharm.2018.07.007. Epub 2018 Jul 7.

PMID:
29990472
7.

Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001.

Vrooman LM, Blonquist TM, Harris MH, Stevenson KE, Place AE, Hunt SK, O'Brien JE, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Sulis ML, Welch JJG, Neuberg DS, Sallan SE, Silverman LB.

Blood Adv. 2018 Jun 26;2(12):1449-1458. doi: 10.1182/bloodadvances.2018016584.

8.

Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.

Athale UH, Puligandla M, Stevenson KE, Asselin B, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Sulis ML, Welch JJG, Harris MH, Neuberg DS, Sallan SE, Silverman LB.

Pediatr Blood Cancer. 2018 Oct;65(10):e27256. doi: 10.1002/pbc.27256. Epub 2018 Jun 7.

PMID:
29878490
9.

Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.

Sulis ML, Blonquist TM, Stevenson KE, Hunt SK, Kay-Green S, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JG, Neuberg DS, Sallan SE, Silverman LB.

Pediatr Blood Cancer. 2018 Aug;65(8):e27082. doi: 10.1002/pbc.27082. Epub 2018 Apr 25. No abstract available.

PMID:
29693795
10.

Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.

Tran TH, Harris MH, Nguyen JV, Blonquist TM, Stevenson KE, Stonerock E, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJG, Reshmi SC, Neuberg DS, Sallan SE, Loh ML, Silverman LB.

Blood Adv. 2018 Mar 13;2(5):529-533. doi: 10.1182/bloodadvances.2017014704.

11.

Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.

Sulis ML, Blonquist TM, Stevenson KE, Hunt SK, Kay-Green S, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JG, Neuberg DS, Sallan SE, Silverman LB.

Pediatr Blood Cancer. 2018 May;65(5):e26952. doi: 10.1002/pbc.26952. Epub 2018 Jan 10.

PMID:
29319209
12.

An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.

Kahn JM, Cole PD, Blonquist TM, Stevenson K, Jin Z, Barrera S, Davila R, Roberts E, Neuberg DS, Athale UH, Clavell LA, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJG, Sallan SE, Silverman LB, Kelly KM.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26871. Epub 2017 Nov 1.

13.

Liposomal Cytarabine Induces Less Neurocognitive Dysfunction Than Intrathecal Methotrexate in an Animal Model.

Thomsen AM, Gulinello ME, Wen J, Schmiegelow K, Cole PD.

J Pediatr Hematol Oncol. 2018 Mar;40(2):e91-e96. doi: 10.1097/MPH.0000000000000888.

14.

Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.

Maxwell RR, Cole PD.

Curr Hematol Malig Rep. 2017 Jun;12(3):176-186. doi: 10.1007/s11899-017-0376-z. Review.

PMID:
28317081
15.

A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.

Finkelstein Y, Blonquist TM, Vijayanathan V, Stevenson KE, Neuberg DS, Silverman LB, Vrooman LM, Sallan SE, Cole PD.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26393. Epub 2016 Dec 13.

PMID:
27957785
16.

Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.

Sands SA, Harel BT, Savone M, Kelly K, Vijayanathan V, Welch JG, Vrooman L, Silverman LB, Cole PD.

Support Care Cancer. 2017 Feb;25(2):449-457. doi: 10.1007/s00520-016-3422-9. Epub 2016 Oct 10.

17.

How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic.

Kahn JM, Athale UH, Clavell LA, Cole PD, Leclerc JM, Laverdiere C, Michon B, Schorin MA, Welch JJ, Sallan SE, Silverman LB, Kelly KM.

J Pediatr Health Care. 2017 Jan - Feb;31(1):e1-e6. doi: 10.1016/j.pedhc.2016.06.004. Epub 2016 Jul 25.

18.

Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study.

Ladas EJ, Orjuela M, Stevenson K, Cole PD, Lin M, Athale UH, Clavell LA, Leclerc JM, Michon B, Schorin MA, Welch JG, Asselin BL, Sallan SE, Silverman LB, Kelly KM.

Nutrition. 2016 Oct;32(10):1103-1109.e1. doi: 10.1016/j.nut.2016.03.014. Epub 2016 Mar 28.

19.

Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL).

Drachtman RA, Masterson M, Shenkerman A, Vijayanathan V, Cole PD.

Leuk Lymphoma. 2016 Oct;57(10):2275-80. doi: 10.3109/10428194.2016.1141406. Epub 2016 Feb 16.

PMID:
26879921
20.
21.

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.

Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, Supko JG, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJ, Lipshultz SE, Kutok JL, Blonquist TM, Neuberg DS, Sallan SE, Silverman LB.

Lancet Oncol. 2015 Dec;16(16):1677-90. doi: 10.1016/S1470-2045(15)00363-0. Epub 2015 Nov 6.

PMID:
26549586
22.

Does genetic susceptibility increase risk for neurocognitive decline among patients with acute lymphoblastic leukemia?

Cole PD.

Future Oncol. 2015;11(13):1855-8. doi: 10.2217/fon.15.117. No abstract available.

PMID:
26161922
23.

Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia.

Cole PD, Finkelstein Y, Stevenson KE, Blonquist TM, Vijayanathan V, Silverman LB, Neuberg DS, Sallan SE, Robaey P, Waber DP.

J Clin Oncol. 2015 Jul 1;33(19):2205-11. doi: 10.1200/JCO.2014.59.0273. Epub 2015 May 18.

24.

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.

Horton TM, Drachtman RA, Chen L, Cole PD, McCarten K, Voss S, Guillerman RP, Buxton A, Howard SC, Hogan SM, Sheehan AM, López-Terrada D, Mrazek MD, Agrawal N, Wu MF, Liu H, De Alarcon PA, Trippet TM, Schwartz CL.

Br J Haematol. 2015 Jul;170(1):118-22. doi: 10.1111/bjh.13388. Epub 2015 Apr 1.

25.

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

Perales MA, Ceberio I, Armand P, Burns LJ, Chen R, Cole PD, Evens AM, Laport GG, Moskowitz CH, Popat U, Reddy NM, Shea TC, Vose JM, Schriber J, Savani BN, Carpenter PA; American Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2015 Jun;21(6):971-83. doi: 10.1016/j.bbmt.2015.02.022. Epub 2015 Mar 12.

26.

γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells.

Kim SE, Hinoue T, Kim MS, Sohn KJ, Cho RC, Cole PD, Weisenberger DJ, Laird PW, Kim YI.

Genes Nutr. 2015 Jan;10(1):444. doi: 10.1007/s12263-014-0444-0. Epub 2014 Dec 13.

27.

Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.

Harker-Murray PD, Drachtman RA, Hodgson DC, Chauvenet AR, Kelly KM, Cole PD.

Pediatr Blood Cancer. 2014 Apr;61(4):579-86. doi: 10.1002/pbc.24851. Epub 2013 Nov 8. Review.

PMID:
24504790
28.

An 18-year-old with nephrotic syndrome and chest pain: questions.

Becton LJ, Goilav B, Wang Y, Cole PD, Kaskel F.

Pediatr Nephrol. 2015 Feb;30(2):267, 269-71. doi: 10.1007/s00467-013-2646-x. Epub 2013 Nov 22. No abstract available.

PMID:
24263530
29.

γ-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexate.

Kim SE, Cole PD, Cho RC, Ly A, Ishiguro L, Sohn KJ, Croxford R, Kamen BA, Kim YI.

Br J Cancer. 2013 Oct 15;109(8):2175-88. doi: 10.1038/bjc.2013.579. Epub 2013 Sep 17.

30.

Memantine protects rats treated with intrathecal methotrexate from developing spatial memory deficits.

Cole PD, Vijayanathan V, Ali NF, Wagshul ME, Tanenbaum EJ, Price J, Dalal V, Gulinello ME.

Clin Cancer Res. 2013 Aug 15;19(16):4446-54. doi: 10.1158/1078-0432.CCR-13-1179. Epub 2013 Jul 5.

31.

Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma.

Kelly KM, Hodgson D, Appel B, Chen L, Cole PD, Horton T, Keller FG; COG Hodgkin Lymphoma Committee.

Pediatr Blood Cancer. 2013 Jun;60(6):972-8. doi: 10.1002/pbc.24423. Epub 2012 Dec 19. Review.

PMID:
23255501
32.

A paradigm shift in correcting medial orbital fracture-related enophthalmos: volumetric augmentation through a lateral approach.

McNichols CH, Hatef DA, Thornton JF, Cole PD, de Mitchell CA, Hollier LH Jr.

J Craniofac Surg. 2012 May;23(3):762-6. doi: 10.1097/SCS.0b013e31824dbda4.

PMID:
22565899
33.

Optimizing pediatric interdental fixation by use of a paramedian palatal fixation site.

McNichols CH, Hatef DA, Cole PD, Hollier LH Jr.

J Craniofac Surg. 2012 Mar;23(2):605-7. doi: 10.1097/SCS.0b013e31824cd7af.

PMID:
22446427
34.

Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist.

Vijayanathan V, Gulinello M, Ali N, Cole PD.

Behav Brain Res. 2011 Dec 1;225(2):491-7. doi: 10.1016/j.bbr.2011.08.006. Epub 2011 Aug 12.

PMID:
21856332
35.

A comparative, long-term assessment of four soft tissue substitutes.

Cole PD, Stal D, Sharabi SE, Hicks J, Hollier LH Jr.

Aesthet Surg J. 2011 Aug;31(6):674-81. doi: 10.1177/1090820X11415393.

PMID:
21813881
36.

Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia.

Mahadeo KM, Wolgast L, McMahon C, Cole PD.

Pediatr Blood Cancer. 2011 Oct;57(4):684-7. doi: 10.1002/pbc.23026. Epub 2011 Feb 4.

PMID:
21671435
37.

The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.

Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdière C, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, Sallan SE.

Eur J Cancer. 2011 Jun;47(9):1373-9. doi: 10.1016/j.ejca.2011.03.022. Epub 2011 Apr 20.

38.

Is primary thinning of the anterolateral thigh flap recommended?

Sharabi SE, Hatef DA, Koshy JC, Jain A, Cole PD, Hollier LH Jr.

Ann Plast Surg. 2010 Dec;65(6):555-9. doi: 10.1097/SAP.0b013e3181cbfebc. Review.

PMID:
21042193
39.

Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report.

Cole PD, McCarten KM, Drachtman RA, Alarcon Pd, Chen L, Trippett TM, Schwartz CL.

Pediatr Hematol Oncol. 2010 Nov;27(8):650-7. doi: 10.3109/08880018.2010.504250.

40.

Keloids: pathogenesis, clinical features, and management.

Chike-Obi CJ, Cole PD, Brissett AE.

Semin Plast Surg. 2009 Aug;23(3):178-84. doi: 10.1055/s-0029-1224797.

41.

Laser therapy in ethnic populations.

Cole PD, Hatef DA, Kaufman Y, Pozner JN.

Semin Plast Surg. 2009 Aug;23(3):173-7. doi: 10.1055/s-0029-1224796.

42.

Skin care in ethnic populations.

Cole PD, Hatef DA, Taylor S, Bullocks JM.

Semin Plast Surg. 2009 Aug;23(3):168-72. doi: 10.1055/s-0029-1224795.

43.

Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS.

Mahadeo KM, Cole PD.

Blood. 2010 May 6;115(18):3852. doi: 10.1182/blood-2010-02-269233. No abstract available. Erratum in: Blood. 2010 Aug 12;116(6):1017.

44.

Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.

Li Y, Vijayanathan V, Gulinello M, Cole PD.

Pharmacol Biochem Behav. 2010 Jun;95(4):428-33. doi: 10.1016/j.pbb.2010.03.003. Epub 2010 Mar 21.

PMID:
20332001
45.

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).

Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, O'Holleran EW, Neuberg DS, Cohen HJ, Sallan SE.

Leukemia. 2010 Feb;24(2):320-34. doi: 10.1038/leu.2009.253. Epub 2009 Dec 17.

46.

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.

Silverman LB, Supko JG, Stevenson KE, Woodward C, Vrooman LM, Neuberg DS, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Laverdière C, Michon B, Schorin M, Schwartz CL, O'Brien JE, Cohen HJ, Sallan SE.

Blood. 2010 Feb 18;115(7):1351-3. doi: 10.1182/blood-2009-09-245951. Epub 2009 Dec 10.

47.

Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats.

Li Y, Vijayanathan V, Gulinello ME, Cole PD.

Pharmacol Biochem Behav. 2010 Jan;94(3):454-63. doi: 10.1016/j.pbb.2009.10.008. Epub 2009 Nov 1.

PMID:
19887080
48.

Contemporary management of pediatric facial trauma.

Hatef DA, Cole PD, Hollier LH Jr.

Curr Opin Otolaryngol Head Neck Surg. 2009 Aug;17(4):308-14. doi: 10.1097/MOO.0b013e32832d95a0. Review.

PMID:
19528801
49.

Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.

Cole PD, Schwartz CL, Drachtman RA, de Alarcon PA, Chen L, Trippett TM.

J Clin Oncol. 2009 Mar 20;27(9):1456-61. doi: 10.1200/JCO.2008.20.3778. Epub 2009 Feb 17.

50.

Optimizing miniplate fixation for simple mandibular fractures.

Cole PD, Kaufman Y, Hatef DA, Hollier LH.

Plast Reconstr Surg. 2009 Feb;123(2):691-3. doi: 10.1097/PRS.0b013e318195668e. Review.

PMID:
19182630

Supplemental Content

Support Center